Patents by Inventor Randolph Hampton

Randolph Hampton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Genes and proteins controlling cholesterol synthesis
    Patent number: 6531292
    Abstract: The present invention provides isolated nucleic acid sequences which encode a family of HMG-CoA Reductase Degradation (HRD) polypeptides. More particularly, the present invention provides isolated HRD1, HRD2 and HRD3 nucleic acids and the Hrd polypeptides encoded by such nucleic acids, i.e., Hrd1, Hrd2 and Hrd3, respectively. Vectors comprising the nucleic acids are provided. In addition, the present invention provides screening assay related to cholesterol biosynthesis.
    Type: Grant
    Filed: July 28, 2000
    Date of Patent: March 11, 2003
    Assignee: The Regents of the University of California
    Inventors: Jasper D. Rine, Randolph Hampton
  • Genes and proteins controlling cholesterol synthesis
    Patent number: 6333172
    Abstract: The present invention provides isolated nucleic acid sequences which encode a family of HMG-CoA Reductase Degradation (HRD) polypeptides. More particularly, the present invention provides isolated HRD1, HRD2 and HRD3 nucleic acids and the Hrd polypeptides encoded by such nucleic acids, i.e., Hrd1, Hrd2 and Hrd3, respectively. Vectors comprising the nucleic acids are provided. In addition, the present invention provides screening assay related to cholesterol biosynthesis.
    Type: Grant
    Filed: January 11, 1999
    Date of Patent: December 25, 2001
    Assignee: The Regents of the University of California
    Inventors: Jasper D. Rine, Randolph Hampton
  • Genes and proteins controlling cholesterol synthesis
    Patent number: 6107462
    Abstract: The present invention provides isolated nucleic acid sequences which encode a family of HMG-CoA Reductase Degradation (HRD) polypeptides. More particularly, the present invention provides isolated HRD1, HRD2 and HRD3 nucleic acids and the Hrd polypeptides encoded by such nucleic acids, i.e., Hrd1, Hrd2 and Hrd3, respectively. Vectors comprising the nucleic acids are provided. In addition, the present invention provides screening assay related to cholesterol biosynthesis.
    Type: Grant
    Filed: August 16, 1996
    Date of Patent: August 22, 2000
    Assignee: The Regents of the University of California
    Inventors: Jasper D. Rine, Randolph Hampton